Study on the Clinical Efficacy of Yishen and Turbid Decoction in Treating Chronic Kidney Disease

Clinical effect study on serum creatinine of stage 3 patients with chronic kidney disease treated by Yishen and Turbid Decoction

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100047567

Enrollment

Unknown

Registered

2021-06-20

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

treatment group:Yishen Jiangzhuo recipe

control group:Conservative treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with stage III chronic kidney disease.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Creatinine;	—

Countries

China

Contacts

Public ContactMa Hongzhen

734837442@qq.com+86 15258808620

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026